PeerLINC Webinar Highlights Early Monitoring of Adverse Events in DR-TB Care
PeerLINC’s first Webinar Series session explored practical approaches to recognizing and managing adverse events during DR-TB treatment, with a focus on peripheral neuropathy and optic neuritis.
G-TEC Members Examine Complex Treatment Decisions in Two DR-TB Cases
A G-TEC online discussion brings together DR-TB experts to examine complex clinical cases, share practical insights, and strengthen treatment decision-making across settings.
PeerLINC Helps Southeast Asian TB Programs Turn DR-TB Guidance into Country Action
PeerLINC convened TB leaders from seven Southeast Asian countries in the Philippines to help turn WHO guidance on shorter, all-oral DR-TB regimens into country action through peer exchange, field learning, and practical implementation planning.
When TB Isn’t TB: Why Frontline Teams Must Spot Paragonimiasis Early
For those of us working in TB control, one hard truth is this: not every chronic cough, episode of hemoptysis, or abnormal chest X-ray is tuberculosis. That challenge was the focus of the May 2026 PeerLINC webinar "When TB Isn’t TB: A Shared Clinical Challenge We Can’t Ignore," led by PeerLINC’s Global Technical Expert Council (G-TEC).
Learning from the Frontlines: PeerLINC Hosts Polish Delegation for Immersive DR-TB Training in the Philippines
PeerLINC hosted a delegation of Polish tuberculosis (TB) health professionals for an intensive clinical immersion focused on drug-resistant TB (DR-TB) management within the Philippine healthcare setting.
February Highlights: APRC Presentation & Virtual Learning
PeerLINC continues to build on its momentum this February, shifting its spotlight from Latin America to Asia in Bangkok
Field Notes: January in Brazil Peer-Led Learning Speeds DR-TB Treatment Knowhow in African Countries
In January 2026, São Paulo saw the successful collaboration of PeerLINC Knowledge Hub and TB Alliance with Brazil’s National Tuberculosis Program (NTP) : hosting a five‑day learning event for six Portuguese‑speaking, high‑burden African countries: Angola, Cabo Verde, Guinea‑Bissau, Mozambique, and São Tomé and Príncipe.
Advancing inclusive DR-TB treatment: reflections from the BDLLfxC global learning session by PeerLINC
A new PeerLINC global learning session highlights how the BDLLfxC regimen is opening the door to more inclusive, family-centered DR-TB care—bringing shorter, safer treatment to groups who have not yet been able to realize the full benefits of new, shorter regimens.
Stronger Together: Countries Praise PeerLINC’s Model as a Key Contributor to Progress Against DR-TB
Born from the Philippines’ early leadership in rolling out six-month DR-TB regimens, PeerLINC has rapidly grown into a global hub where countries learn directly from one another to modernize TB care. Its peer-to-peer model is reshaping how technical assistance is delivered and helping nations to quickly bring shorter, safer treatments to those who need them.
Preparing for Tomorrow’s Innovations Today: New Trial Results Demonstrate Potential of “SPaL” Regimen to Shorten and Simplify TB Therapy
As the NC-009 trial points to a powerful new TB regimen, the results emphasize why platforms like PeerLINC are essential for translating scientific progress into timely, scalable access worldwide.